Non-cystic Fibrosis Bronchiectasis Clinical Trials

66 clinical trials for Non-cystic Fibrosis Bronchiectasis across international registries, including 17 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Adult Study Participants With Non-Cystic Fibrosis Bronchiectasis — RECRUITING · PHASE2
• A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis — RECRUITING · PHASE2
• A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease — RECRUITING · PHASE1
• A Phase 1a/1b Study to Investigate the Safety, Tolerability, Microbiological Response, and Pharmacokinetics of Inhaled Rev-56 in Adult Healthy Volunteers and Adult Non-cystic Fibrosis Bronchiectasis (NCFB) Patients With Chronic P. Aeruginosa — RECRUITING · PHASE1
• A Translational Study for Phenotyping and Endotyping Chinese Patients With NCFBE — RECRUITING
• Long-term Evaluation of the SIMEOX Device at Home in Non-cystic Fibrosis Bronchiectasis — RECRUITING · NA
• A Study to Assess the Safety of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis — RECRUITING · PHASE3
• BASE: Bronchiectasis Severity and Exacerbation Risk Study — RECRUITING
• Bronchiectasis Phenotype Identification Model — RECRUITING
• A RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED, PARALLEL-GROUP, PHASE 2A PARTICIPANTS WITH NON-CYSTIC FIBROSIS BRONCHIECTASIS (NCFB) STUDY TO ASSESS THE ACTIVITY, SAFETY, AND TOLERABILITY OF SAR445399 IN ADULT — RECRUITING · PHASE2
• A Clinical Study of RSS0343 in Healthy Subjects — RECRUITING · PHASE1
• Breathing Training and Exercise Capacity in Non-CFB — RECRUITING · NA
• Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults With Non-cystic Fibrosis Bronchiectasis (NCFB) — RECRUITING · PHASE2
• Hypertonic Saline in NCFB — RECRUITING · PHASE4
• A Study to Assess the Efficacy and Safety of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis — RECRUITING · PHASE3
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP, PROOF-OFCONCEPT (POC) STUDY TO ASSESS THE EFFICACY, SAFETY AND TOLERABILITY OF ITEPEKIMAB, IN PARTICIPANTS WITH NON-CYSTIC FIBROSIS BRONCHIECTASIS — RECRUITING
• A MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED, 52 WEEK, PHASE III STUDY WITH AN OPEN-LABEL EXTENSION TO EVALUATE THE EFFICACY AND SAFETY OF BENRALIZUMAB IN PATIENTS WITH NON-CYSTIC FIBROSIS BRONCHIECTASIS (MAHALE) — RECRUITING · PHASE3
• A Study to Access Activity and Safety With SAR445399 Compared With Placebo in Participants Aged 18 to 80 Years of Age With Non-Cystic Fibrosis Bronchiectasis — SUSPENDED · PHASE2
• HFCWO in Children With Non-CF Bronchiectasis — NOT_YET_RECRUITING · NA
• A Phase II, Randomized, Double-Blind, PlaceboControlled Study of Ensifentrine in Subjects with Non-Cystic Fibrosis Bronchiectasis — TERMINATED · PHASE2
• A Randomized, Double-blinded, Placebo-controlled, Parallel Group, Phase 2a Study to Assess the Activity, Safety, and Tolerability of SAR445399 in Adult Participants with Non-Cystic Fibrosis Bronchiectasis (NCFB). — NOT_YET_RECRUITING · PHASE2
• Azithromycin to Modify Bronchiectasis Exacerbation Risk — NOT_YET_RECRUITING · PHASE4
• Feasibility and Acceptance of SonoHeal for Airway Clearance and Preliminary Comparison With the Standard of Care — ACTIVE_NOT_RECRUITING
• A Phase 2b, Multicenter, Randomized, Double-blind, Parallel group, Placebo-controlled, Dose Range Finding Study to Evaluate the Efficacy, Safety, and Tolerability of Nebulized CSL787 in Adults (18 to 85 years) with Non-cystic Fibrosis Bronchiectasis — NOT_YET_RECRUITING · PHASE2
• Nebulised RESP30X Nitric Oxide Formulations in NCFB Patients With Pseudomonas Aeruginosa (Pa) — ACTIVE_NOT_RECRUITING · PHASE1
• Trikafta for Patients With Non-cystic Fibrosis Bronchiectasis — COMPLETED · PHASE4
• Digital Physiotherapy for Pediatric Chronic Suppurative Lung Diseases — NOT_YET_RECRUITING · NA
• Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection — COMPLETED · PHASE2
• A Study to Assess the Efficacy, Safety, and Tolerability of Brensocatib in Participants With Non-Cystic Fibrosis Bronchiectasis — COMPLETED · PHASE3
• An Expanded Access Study to Assess Brensocatib for Participants With Non-Cystic Fibrosis Bronchiectasis — OTHER
• Phase 2a, 28-day Investigational Use Study of ARINA-1 in Non-Cystic Fibrosis Bronchiectasis (NCFBE) With Excess Mucus and Cough — COMPLETED · PHASE2
• Efficacy and Safety of Benralizumab in Patients With Non-cystic Fibrosis Bronchiectasis — TERMINATED · PHASE3
• A Multicenter, Randomized, Double-blind, Placebo-controlled Parallel-group Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of XH-S004 Tablets in Patients With Non-cystic Fibrosis Bronchiectasis — NOT_YET_RECRUITING · PHASE2
• Impact of Support Groups for Patients With Non-Cystic Fibrosis Bronchiectasis — COMPLETED · NA
• Nutritional Status and Intake in Patients With Non-cystic Fibrosis Bronchiectasis (NCFB) — COMPLETED
• Not applicable — OTHER · PHASE1
• Simeox Therapy at Home Versus Standard of Care in NCFB Patients With CMH — COMPLETED · NA
• Roflumilast in Non-CF Bronchiectasis Study (2019) — COMPLETED · PHASE2
• Observational Study of Sputum Inflammation Phenotypes and Clinical Outcomes in Non-Cystic Fibrosis Bronchiectasis — NOT_YET_RECRUITING
• A Study in Patients With Non-cystic Fibrosis Bronchiectasis to Test How Well Different Doses of BI 1323495 Are Tolerated and How BI 1323495 Affects Biomarkers of Inflammation — TERMINATED · PHASE1
• A Study of HSK31858 in Participants with Non-Cystic Fibrosis Bronchiectasis — COMPLETED · PHASE2
• A Study to Evaluate the Effect of Probiotic Supplement on Quality of Life — COMPLETED · NA
• Procalcitonin as a Marker of Severity of Non-cystic Fibrosis Bronchiectasis in Children — OTHER
• Early Detection of Pulmonary Exacerbations in Non-cystic Fibrosis Bronchiectasis — OTHER
• Trial in Non-cystic Fibrosis Bronchiectasis Patients With Chronic Lung Infections Treated With Colistimethate Sodium. — TERMINATED · PHASE3
• Efficacy and Safety of Inhaled CMS in Bronchiectasis Subjects With Chronic P. Aeruginosa Infection. (PROMIS-I) — COMPLETED · PHASE3
• Assessment of INS1007 in Participants With Non-Cystic Fibrosis Bronchiectasis — COMPLETED · PHASE2
• Exercise Capacity in Non-cystic Fibrosis Bronchiectasis After a Pulmonary Rehabilitation Home-based Program — COMPLETED · NA
• A Clinical Study to Investigate Safety, Tolerability and Distribution of CHF 6333 After One or After Repeated Inhalation in Patients With Cystic Fibrosis (CF) and in Patients With Non Cystic Fibrosis (NCFB) Bronchiectasis — COMPLETED · PHASE1
• Phase 3 Study With Ciprofloxacin Dispersion for Inhalation in Non-CF Bronchiectasis (ORBIT-4) — COMPLETED · PHASE3

Refine this search